Former President Joe Biden has commenced radiation and hormone therapy for an aggressive form of prostate cancer, as confirmed by his spokesperson. The 82-year-old leader’s diagnosis came after he reported urinary symptoms, with the cancer having metastasized to his bones. His medical evaluation revealed a Gleason score of 9, categorizing it as one of the most aggressive types of prostate cancer.
Biden’s spokesperson, Kelly Scully, shared the details of his treatment plan, stating, “As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone treatment.” This announcement follows Biden’s departure from office in January 2023, after he chose not to seek reelection amid concerns regarding his age and health.
In May 2023, Biden’s post-presidential office disclosed his diagnosis, indicating that the cancer had advanced to his bones. The former president’s health has become a focal point for public discussion, especially considering he served as the oldest president in U.S. history.
In addition to his prostate cancer treatment, Biden underwent surgery last month to remove skin cancer lesions from his forehead. This ongoing medical care has intensified discussions about the health and age of national leaders, particularly in the context of Biden’s significant role in American politics.
Prostate cancer is assessed for aggressiveness using the Gleason scoring system, which ranges from 6 to 10. Scores of 8, 9, and 10 indicate a more aggressive disease, which aligns with Biden’s diagnosis. His treatment plan aims to manage the aggressive nature of the illness effectively.
The former president’s health situation serves as a reminder of the challenges faced by aging leaders. As Biden continues his treatment, the public and political communities remain attentive to his progress and the implications for future leadership.